Table 2.

Effect of ISIS 2302 on the Correction of the PTT by Activated Coagulation Factor in Factor-Deficient Plasma

Plasma Factor Added Control (sec) 50 μg/mL ISIS 2302 (sec)
Normal  None  31.9 ± 0.5 49.2 ± 3.1  
Factor XI deficient  None  99.9 ± 4.1 ND  
 15 nmol/L fXIa  31.8 ± 0.6  50.0 ± 1.2 
Factor IX deficient  None  102.6 ± 3.6  ND  
 20 nmol/L fIXa  31.9 ± 1.0  52.9 ± 1.3  
Factor VIII deficient  None  82.7 ± 1.0  ND  
 0.01 U/mL fVIIIa 31.1 ± 0.5  50.9 ± 0.5  
Factor X deficient  None 147.2 ± 11.9  ND  
 0.2 nmol/L fXa  30.5 ± 0.1 32.1 ± 0.8  
Factor V deficient  None  183.6 ± 0.1 ND  
 0.015 U/mL fVa  31.1 ± 0.3 48.4 ± 0.5 
Plasma Factor Added Control (sec) 50 μg/mL ISIS 2302 (sec)
Normal  None  31.9 ± 0.5 49.2 ± 3.1  
Factor XI deficient  None  99.9 ± 4.1 ND  
 15 nmol/L fXIa  31.8 ± 0.6  50.0 ± 1.2 
Factor IX deficient  None  102.6 ± 3.6  ND  
 20 nmol/L fIXa  31.9 ± 1.0  52.9 ± 1.3  
Factor VIII deficient  None  82.7 ± 1.0  ND  
 0.01 U/mL fVIIIa 31.1 ± 0.5  50.9 ± 0.5  
Factor X deficient  None 147.2 ± 11.9  ND  
 0.2 nmol/L fXa  30.5 ± 0.1 32.1 ± 0.8  
Factor V deficient  None  183.6 ± 0.1 ND  
 0.015 U/mL fVa  31.1 ± 0.3 48.4 ± 0.5 

PTT was performed as described (see Materials and Methods) in normal or factor-deficient plasma in the presence or absence of oligonucleotide. Sufficient activated coagulation factor was added during recalcification to correct the clotting time to control values without oligonucleotide present. Clotting times are expressed as the mean (sec) ± SD.

Abbreviation: ND, not determined.

Close Modal

or Create an Account

Close Modal
Close Modal